Peak viral loads in D+R- transplant recipients, for the first compared to any subsequent episodes of viraemia, before (A) and after (B) change in protocol. Line shows median value, box shows interquartile range and bars indicate range. Non-viraemic patients excluded.</p
Background: Cytomegalovirus (CMV) infection in immunocompromised patients can lead to viremia associ...
Cytomegalovirus (CMV) DNA load was analyzed as a marker for relapse of CMV infection in 24 solid org...
<p><b>(A)</b> SHIV plasma viral loads from Group A animals transplanted prior to infection. <b>(B)</...
Peak viral loads in the three DR groups D+R- (A), D+R+ (B) and D-R+ (C) transplant recipients, befor...
Duration of viraemia (A,B,C) and treatment (D,E,F) in the three DR groups D+R- (A,D), D+R+ (B,E) and...
BACKGROUND:Human cytomegalovirus (HCMV) can be managed by monitoring HCMV DNA in the blood and givin...
BackgroundHuman cytomegalovirus (HCMV) can be managed by monitoring HCMV DNA in the blood and giving...
BACKGROUND: Human cytomegalovirus (HCMV) can be managed by monitoring HCMV DNA in the blood and givi...
To help decide when to start and when to stop pre-emptive therapy for cytomegalovirus infection, we ...
The availability of valganciclovir (VGCV)has significantlysim-plified the treatment of human cytomeg...
To help decide when to start and when to stop pre-emptive therapy for cytomegalovirus infection, we ...
<div><p>Background</p><p>To help decide when to start and when to stop pre-emptive therapy for cytom...
grantor: University of TorontoThe early detection of cytomegalovirus (CMV) reactivation af...
grantor: University of TorontoThe early detection of cytomegalovirus (CMV) reactivation af...
Ve D(+)R(-) KT patients. Black bars indicate median, whiskers indicate interquartile range. P-values...
Background: Cytomegalovirus (CMV) infection in immunocompromised patients can lead to viremia associ...
Cytomegalovirus (CMV) DNA load was analyzed as a marker for relapse of CMV infection in 24 solid org...
<p><b>(A)</b> SHIV plasma viral loads from Group A animals transplanted prior to infection. <b>(B)</...
Peak viral loads in the three DR groups D+R- (A), D+R+ (B) and D-R+ (C) transplant recipients, befor...
Duration of viraemia (A,B,C) and treatment (D,E,F) in the three DR groups D+R- (A,D), D+R+ (B,E) and...
BACKGROUND:Human cytomegalovirus (HCMV) can be managed by monitoring HCMV DNA in the blood and givin...
BackgroundHuman cytomegalovirus (HCMV) can be managed by monitoring HCMV DNA in the blood and giving...
BACKGROUND: Human cytomegalovirus (HCMV) can be managed by monitoring HCMV DNA in the blood and givi...
To help decide when to start and when to stop pre-emptive therapy for cytomegalovirus infection, we ...
The availability of valganciclovir (VGCV)has significantlysim-plified the treatment of human cytomeg...
To help decide when to start and when to stop pre-emptive therapy for cytomegalovirus infection, we ...
<div><p>Background</p><p>To help decide when to start and when to stop pre-emptive therapy for cytom...
grantor: University of TorontoThe early detection of cytomegalovirus (CMV) reactivation af...
grantor: University of TorontoThe early detection of cytomegalovirus (CMV) reactivation af...
Ve D(+)R(-) KT patients. Black bars indicate median, whiskers indicate interquartile range. P-values...
Background: Cytomegalovirus (CMV) infection in immunocompromised patients can lead to viremia associ...
Cytomegalovirus (CMV) DNA load was analyzed as a marker for relapse of CMV infection in 24 solid org...
<p><b>(A)</b> SHIV plasma viral loads from Group A animals transplanted prior to infection. <b>(B)</...